Radnostix (INIS) Capital Expenditures (2010 - 2026)
Radnostix's Capital Expenditures came in at $205,175 for Q1 2026, up 59.2% from $128,881 a year earlier but down 26.7% from the prior quarter.
Powered by 
Analysis
Radnostix (INIS) Capital Expenditures (2010 - 2026) Analysis & Trends
For FY2025, Radnostix's Capital Expenditures was $534,155, down 25.9% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 133.2% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $721,215 in FY2024 (+383.8%), $149,058 in FY2023 (+24.2%), $120,014 in FY2022 (-41.6%) and $205,474 in FY2021.
- The five-year range for quarterly Capital Expenditures is -$401,571 (Q4 2023) to $484,107 (Q3 2023).
- Year-over-year, Capital Expenditures increased in four of the last seven quarters, with growth averaging 25.2%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2021 (growth of 774.4%), and the weakest in Q3 2024 (a decline of 89.2%).
- Business Quant data shows INIS's Capital Expenditures at $279,764 (Q4 2025), $64,017 (Q3 2025) and $61,493 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Radnostix | 23.81 Mn | 17.92 Mn | 1.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 205,175.00 |
| Dec 31, 2025 | 279,764.00 |
| Sep 30, 2025 | 64,017.00 |
| Jun 30, 2025 | 61,493.00 |
| Mar 31, 2025 | 128,881.00 |
| Dec 31, 2024 | 453,908.00 |
| Sep 30, 2024 | 52,371.00 |
| Jun 30, 2024 | 44,015.00 |
| Mar 31, 2024 | 170,921.00 |
| Dec 31, 2023 | -401,571.00 |
| Sep 30, 2023 | 484,107.00 |
| Jun 30, 2023 | 14,320.00 |
| Mar 31, 2023 | 52,202.00 |
| Dec 31, 2022 | 51,739.00 |
| Sep 30, 2022 | 13,075.00 |
| Jun 30, 2022 | 4,100.00 |
| Mar 31, 2022 | 51,100.00 |
| Dec 31, 2021 | 8,744.00 |
| Sep 30, 2021 | 5,064.00 |
| Jun 30, 2021 | 32,911.00 |
API Access
Radnostix Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "INIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=INIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();